SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs FEops HEARTguide

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

FEops HEARTguide

by FEops NV

AI Verdict

Tool A, SENSICARDIAC MOBI, is designed for the diagnostic assessment of heart murmurs by analyzing acoustic signals from an electronic stethoscope. In contrast, Tool B, FEops HEARTguide, focuses on pre-operative planning for structural heart procedures, utilizing AI and digital twin technology for predictive simulations based on CT scan data. While both are cardiology AI tools, their distinct applications in diagnosis versus surgical planning make them adjacent rather than direct competitors.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if you are a physician in primary care, internal medicine, or pediatrics seeking an AI-powered mobile solution for rapid, initial assessment and differentiation of heart murmurs. This tool is ideal for quickly analyzing acoustic heart signals from an electronic stethoscope to identify suspected murmurs and aid in decision support for further investigation.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose FEops HEARTguide if…

Choose FEops HEARTguide if you are an interventional cardiologist or cardiothoracic surgeon requiring advanced pre-operative planning for structural heart procedures. This cloud-based platform excels at providing patient-specific predictive simulations and anatomical measurements using digital twin technology to optimize device sizing and positioning, thereby enhancing procedural outcomes.

View FEops HEARTguide →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	FEops HEARTguide
Pricing	Contact for pricing	Contact for pricing
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Cloud-based
BAA Available	Yes AI-estimated	Unknown
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Tool A, SensiCardiac Mobi, leverages a familiar mobile application interface for point-of-care heart murmur diagnosis, which suggests a more immediate and accessible user experience. Its FDA clearance document indicates improved usability compared to predicate devices, with high user satisfaction scores.

Clinical Value

FEops HEARTguide

Tool B, FEops HEARTguide, demonstrates superior clinical value through extensive validation and quantifiable improvements in patient outcomes and procedural efficiency for complex structural heart interventions. Clinical trials have shown significant reductions in device usage, repositionings, radiation exposure, and procedural time, directly impacting patient safety and healthcare costs.

Pricing & Value

FEops HEARTguide

While specific pricing is not publicly disclosed for either tool, Tool B offers a more compelling value proposition due to its proven ability to generate significant efficiencies and improved outcomes in high-cost, high-risk structural heart procedures. These quantifiable benefits, such as reduced complications and procedural time, translate to substantial economic and clinical value for healthcare providers.

Enterprise Readiness

FEops HEARTguide

Tool B, FEops HEARTguide, is a cloud-based platform offering anytime, anywhere access, robust security features like multi-factor authentication, and a collaborative environment for case sharing. Its deployment in over 300 hospitals across 27 countries, coupled with DICOM integration, indicates a more mature and scalable enterprise solution compared to Tool A's hosted server and mobile app model.

Innovation

FEops HEARTguide

Tool B, FEops HEARTguide, stands out for its innovative use of digital twin technology combined with AI for patient-specific predictive simulations in structural heart interventions. This cutting-edge approach provides unprecedented insights into device-anatomy interaction, leading to personalized treatment planning. Its innovation has been recognized with multiple industry awards and significant grants.

Support & Docs

FEops HEARTguide

Tool B provides more comprehensive support and documentation, including access to publications, clinical case reports, videos, and training slide decks, along with direct email support channels. While Tool A has a user manual, the available information does not detail a comparable breadth of support resources for its users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	FEops HEARTguide
Tool Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	FEops HEARTguide
Core Function	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals to differentiate between physiological and pathological sounds.	Cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning.
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	FEops NV
Primary Technology Focus	AI-powered analysis of acoustic heart signals for heart murmur diagnosis.	AI and digital twin technology for predictive simulations and anatomical measurements.
Input Data Type	Acoustic heart signals from an electronic stethoscope	DICOM interface for CT scan upload
Target Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Cardiothoracic Surgery

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and FEops HEARTguide.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do SensiCardiac Mobi and FEops HEARTguide integrate into existing clinical workflows, and for what specific patient populations are they best suited?

SensiCardiac Mobi is a mobile application that integrates into the physical exam workflow by acquiring and analyzing acoustic heart signals from an electronic stethoscope, assisting in diagnosing heart murmurs in general cardiology, internal medicine, and pediatric patients. FEops HEARTguide, a cloud-based platform, integrates into pre-operative planning for structural heart procedures by using CT scan uploads to provide predictive simulations and anatomical measurements for optimizing device sizing and positioning in patients requiring interventions like TAVI or LAAO.

What is the depth of EHR integration for each tool, and how does each facilitate data management and audit trails?

SensiCardiac Mobi acquires and records acoustic heart signals and patient information, with reports available as downloadable PDFs, suggesting data export capabilities for EHR integration and audit trails. FEops HEARTguide features a DICOM interface for CT scan upload and generates patient-specific digital replicas and reports, which can be shared, indicating robust data integration for procedural planning and supporting audit-trail features.

What information is available regarding the accuracy and sensitivity of each tool's diagnostic or predictive algorithms?

SensiCardiac Mobi uses the Sensi Diagnostic Heart Murmur Algorithm to distinguish between physiological and pathological heart murmurs, with one study reporting a sensitivity of 84% and specificity of 84% for detecting pathological murmurs compared to echocardiography. FEops HEARTguide's predictive simulations and AI-based anatomical measurements have been shown to improve procedural efficiency and outcomes in LAAO procedures, with studies demonstrating high correlation (ru22650.90) between simulation-based sizing and actual implanted device characteristics.

What is the expected learning curve for physicians and their teams, and how quickly can a practice expect to see clinical value from each tool?

SensiCardiac Mobi, as a mobile application with a guided auscultation process and an intuitive user interface, likely has a relatively short learning curve, allowing for quick adoption and immediate diagnostic support. FEops HEARTguide, a cloud-based platform with interactive 2D and 3D viewers and predictive simulations, may require some training for optimal use, though its aim is to improve procedure efficiency and outcomes, suggesting a rapid time-to-value through optimized planning.

Beyond standard compliance, what advanced security features and audit-trail capabilities do these tools offer to ensure data integrity and accountability?

SensiCardiac Mobi operates on a hosted server environment and records acoustic heart signals, implying data storage that would necessitate audit trails, though specific advanced security features beyond HIPAA are not detailed. FEops HEARTguide, as a cloud-based platform, offers secure access from anywhere and includes features like multi-factor authentication and enforced password changes, along with case sharing capabilities that can be manually or automatically controlled, supporting data integrity and accountability.

What are the key considerations for deploying each tool across multiple clinical sites or a large hospital system?

SensiCardiac Mobi, being a mobile application that requires a user-provided compatible electronic stethoscope, could be scaled across multiple sites by ensuring device availability and user training. FEops HEARTguide, as a cloud-based platform with anytime, anywhere access and a DICOM interface, is designed for multi-site accessibility and collaboration, allowing secure case sharing with peers and industry partners.